Comparison in localization between cystatin C and cathepsin K in osteoclasts and other cells in mouse tibia epiphysis by immunolight and immunoelectron microscopy.

Abstract:

:We compared the distribution of a cysteine proteinase inhibitor, cystatin C, with that of cathepsin K in osteoclasts of the mouse tibia by immunolight and immunoelectron microscopy. Light microscopically, strong immunoreactivity for cystatin C was found extracellularly along the resorption lacuna and intracellularly in the organelles of osteoclasts. In serial sections, various patterns of cystatin C and cathepsin K localization were seen, specifically: (1) some resorption lacuna were positive for both cystatin C and cathepsin K; (2) others were positive for either cystatin C or cathepsin K, but not both; and (3) some lacuna were negative for both. In osteoclasts, the localization of cystatin C was similar to that of cathepsin K. Furthermore, cystatin C immunoreactivity was detected in preosteoclasts and osteoblasts, whereas cathepsin K was seen only in preosteoclasts. Electron microscopically, cystatin C immunoreactive products were found in the rough endoplasmic reticulum (ER), Golgi apparatus, vesicles, granules, and vacuoles of osteoclasts. These cystatin C-positive vesicles had fused or were in the process of fusion with the ampullar vacuoles (extracellular spaces) containing cystatin C-positive, fragmented, fibril-like structures. The extracellular cystatin C was deposited on and between the cytoplasmic processes of ruffled borders, and on and between type I collagen fibrils. In the basolateral region of osteoclasts, cystatin C-positive vesicles and granules also fused with vacuoles that contained cystatin C-positive or negative fibril-like structures. These results indicate that osteoclasts not only synthesize and secrete cathepsin K from the ruffled border into the bone resorption lacunae, but also a cysteine proteinase inhibitor, cystatin C. Therefore, it is suggested that cystatin C regulates the degradation of bone matrix by cathepsin K, both extracellularly and intracellularly.

journal_name

Bone

journal_title

Bone

authors

Yamaza T,Tsuji Y,Goto T,Kido MA,Nishijima K,Moroi R,Akamine A,Tanaka T

doi

10.1016/s8756-3282(01)00466-5

subject

Has Abstract

pub_date

2001-07-01 00:00:00

pages

42-53

issue

1

eissn

8756-3282

issn

1873-2763

pii

S8756-3282(01)00466-5

journal_volume

29

pub_type

杂志文章

相关文献

BONE文献大全
  • Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling.

    abstract::Previous work with cultured primary cells, from our group and from other laboratories, has shown that signals from extracellular matrix, transduced by integrins, play critical roles in regulating gene expression, tissue-specific differentiation, and survival of primary osteoblasts and fibroblasts. This summary will fo...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/s8756-3282(99)00106-4

    authors: Damsky CH

    更新日期:1999-07-01 00:00:00

  • Comparative serum proteome expression of osteonecrosis of the femoral head in adults.

    abstract::Osteonecrosis of the femoral head (ONFH) is a skeletal disorder characterized by ischemic deterioration, bone marrow edema and eventually femoral head collapse. The systemic regulation of ONFH in adult patients has not been examined. Serum proteomic is an innovative tool that potentially detects simultaneous expressio...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.04.019

    authors: Wu RW,Wang FS,Ko JY,Wang CJ,Wu SL

    更新日期:2008-09-01 00:00:00

  • Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model.

    abstract::Administration of perioperative antibiotic prophylaxis is a routine procedure in orthopedic surgery. Besides systemic prophylaxis, only few techniques are established for local application of antibiotics to reduce infection related to orthopedic implants. The aim of this study was to evaluate the efficacy of locally v...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.01.008

    authors: Lucke M,Wildemann B,Sadoni S,Surke C,Schiller R,Stemberger A,Raschke M,Haas NP,Schmidmaier G

    更新日期:2005-05-01 00:00:00

  • The effect of static bone strain on implant stability and bone remodeling.

    abstract::Bone remodeling is a process involving both dynamic and static bone strain. Although there exist numerous studies on the effect of dynamic strain on implant stability and bone remodeling, the effect of static strain has yet to be clarified. Hence, for this purpose, the effect of static bone strain on implant stability...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.07.003

    authors: Halldin A,Jimbo R,Johansson CB,Wennerberg A,Jacobsson M,Albrektsson T,Hansson S

    更新日期:2011-10-01 00:00:00

  • COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.

    abstract:INTRODUCTION:Angiogenesis is closely associated with bone formation, especially endochondral ossification. Angiopoietin 1 (Ang1) is a specific growth factor functioning to generate a stable and matured vasculature through the Tie2 receptor/PI3K/AKT pathway. Recently cartilage oligomeric matrix protein (COMP)-Ang1, an A...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2009.09.019

    authors: Jeong BC,Kim HJ,Bae IH,Lee KN,Lee KY,Oh WM,Kim SH,Kang IC,Lee SE,Koh GY,Kim KK,Koh JT

    更新日期:2010-02-01 00:00:00

  • Has reimbursement of bone mineral density testing and anti-osteoporotic treatments improved management of osteoporosis in France?

    abstract:BACKGROUND:Since July 1, 2006 bone mineral density (BMD) testing has been reimbursed for osteoporosis screening under specific clinical conditions in France. Concurrently, drug coverage has been extended to all anti-osteoporotic treatments in women with low BMD. It was thus expected that the utilisation of BMD testing ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.06.026

    authors: Canoui-Poitrine F,Jaglal S,Chapurlat R,Tainturier V,Colin C,Schott AM

    更新日期:2010-10-01 00:00:00

  • Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma.

    abstract::Recent studies have shown that treatment with bisphosphonates could be effective against the myelomatous skeletal deterioration. However, the mechanisms of action of these drugs in multiple myeloma (MM) have been poorly studied. In the present study, 11 patients with MM and bone lesions were treated orally with 30 mg/...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(94)90890-7

    authors: Roux C,Ravaud P,Cohen-Solal M,de Vernejoul MC,Guillemant S,Cherruau B,Delmas P,Dougados M,Amor B

    更新日期:1994-01-01 00:00:00

  • Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats.

    abstract::The skeletal consequences of streptozotocin-induced (STZ) diabetes in the rat are characterized by decreased bone formation and, consequently, reductions in bone mass. Given the ability of tetracyclines to inhibit the breakdown of connective tissue collagen in experimental diabetes (and in other diseases), we examined...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(97)00104-x

    authors: Bain S,Ramamurthy NS,Impeduglia T,Scolman S,Golub LM,Rubin C

    更新日期:1997-08-01 00:00:00

  • In the ovariectomized rat, tamoxifen conserves bone similarly in parathyroid-intact and parathyroidectomized animals.

    abstract::To examine the ability of tamoxifen (TAM) to conserve bone in the estrogen-deficient ovariectomized (OVX) rat in the presence and absence of parathyroid hormone (PTH) six groups of rats with 45Ca-labeled bones were studied for 12 weeks. Rats were OVX, parathyroidectomized (PTX), or given sham operations and treated wi...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(94)90273-9

    authors: Goulding A,Gold E

    更新日期:1994-09-01 00:00:00

  • Effects of experimental conditions on the release of 45calcium from prelabeled fetal mouse long bones.

    abstract::Embryonic/neonatal bones in culture are commonly used for the study of osteoclastic resorption in vitro. For this purpose, the release of 45calcium (45Ca) from prelabeled bones is measured as an index of resorption. We studied 45Ca release from two types of long bone explants after different preparation methods: 17-da...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(95)00135-z

    authors: van Beek E,Oostendorp-van de Ruit M,van der Wee-Pals L,Bloys H,van de Bent C,Papapoulos S,Löwik C

    更新日期:1995-07-01 00:00:00

  • Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis.

    abstract::Mammalian bone sialoprotein (BSP) is a mineralized tissue-specific protein containing an RGD (arginine-glycine-aspartic acid) cell-attachment sequence and two distinct glutamic acid (glu)-rich regions, with each containing one contiguous glu sequence. These regions have been proposed to contribute to the attachment of...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(00)00392-6

    authors: Harris NL,Rattray KR,Tye CE,Underhill TM,Somerman MJ,D'Errico JA,Chambers AF,Hunter GK,Goldberg HA

    更新日期:2000-12-01 00:00:00

  • Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis.

    abstract:PURPOSE:In the Fracture Prevention Trial, the risks of any nonvertebral fracture (relative risk [RR] 0.65, P=0.04) and any fragility nonvertebral fracture (RR 0.47, P=0.02) were significantly reduced in the teriparatide 20 μg/day (teriparatide) versus placebo group. The purpose of this analysis was to examine the effic...

    journal_title:Bone

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.bone.2011.10.018

    authors: Krege JH,Wan X

    更新日期:2012-01-01 00:00:00

  • Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone.

    abstract::Eldecalcitol (ELD), an active form of vitamin D analog approved for the treatment of osteoporosis in Japan, increases lumbar spine bone mineral density (BMD), suppresses bone turnover markers, and reduces fracture risk in patients with osteoporosis. We have previously reported that treatment with ELD for 6 months impr...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.11.025

    authors: Saito M,Grynpas MD,Burr DB,Allen MR,Smith SY,Doyle N,Amizuka N,Hasegawa T,Kida Y,Marumo K,Saito H

    更新日期:2015-04-01 00:00:00

  • Age- and gender-related differences in cortical geometry and microstructure: Improved sensitivity by regional analysis.

    abstract:OBJECTIVE:While the importance of cortical structure quantification is increasingly underscored by recent literature, conventional analysis techniques obscure potentially important regional variations in cortical structure. The objective of this study was to characterize the spatial variability in cortical geometry and...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.10.031

    authors: Kazakia GJ,Nirody JA,Bernstein G,Sode M,Burghardt AJ,Majumdar S

    更新日期:2013-02-01 00:00:00

  • Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid.

    abstract::A serious side effect of glucocorticoid treatment is the development of osteoporosis. We have earlier shown that long-term glucocorticoid administration results in a decrease in longitudinal bone growth, cortical bone mass, and biomechanical strength, while growth hormone administration increases these parameters. The...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(96)00077-4

    authors: Ortoft G,Oxlund H

    更新日期:1996-06-01 00:00:00

  • Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs).

    abstract::Adipose-derived adult stem cells (ASCs), like their bone-marrow derived counterparts, possess the ability to differentiate down osteogenic, chondrogenic, adipogenic, and myogenic pathways. For bone differentiation of mouse ASCs (mASCs), retinoic-acid mediated upregulation of BMPR-IB has been found to be necessary. Int...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.01.026

    authors: Quarto N,Wan DC,Longaker MT

    更新日期:2008-06-01 00:00:00

  • Effect of inducible bone morphogenetic protein 2 expression on the osteogenic differentiation of dental pulp stem cells in vitro.

    abstract::Bone morphogenetic protein 2 (BMP-2) is a member of the transforming growth factor-β superfamily, it is known to be a factor involved in skeletal development and capable of inducing in vitro osteogenic differentiation of mesenchymal stem cells (MSCs). Dental pulp stem cells (DPSCs) isolated from extracted third molar ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.115214

    authors: Tóth F,Gáll JM,Tőzsér J,Hegedűs C

    更新日期:2020-03-01 00:00:00

  • Delineation of the 1q24.3 microdeletion syndrome provides further evidence for the potential role of non-coding RNAs in regulating the skeletal phenotype.

    abstract::Microdeletions within 1q24 have been associated with growth deficiency, varying intellectual disability, and skeletal abnormalities. The candidate locus responsible for the various phenotypic features of this syndrome has previously been predicted to lie in the area of 1q24.3, but molecular evidence of the causative g...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115705

    authors: Shepherdson JL,Zheng H,Amarillo IE,McAlinden A,Shinawi M

    更新日期:2021-01-01 00:00:00

  • Peroxisome proliferator activated receptor-gamma (PPARgamma) represses thyroid hormone signaling in growth plate chondrocytes.

    abstract::Peroxisome proliferator activated receptors (PPARs) are DNA-binding nuclear hormone receptors that are upregulated in response to high fat diets. PPARs are structurally related to the type II nuclear receptors, including the thyroid hormone receptors (TRs). To investigate if PPARs modulate TR-mediated terminal differe...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.04.031

    authors: Wang L,Shao YY,Ballock RT

    更新日期:2005-09-01 00:00:00

  • Effect of ED-71 on modeling of bone in distraction osteogenesis.

    abstract::We investigated the effect of 2-beta-(3-hydroxypropoxy)-1alpha,25-dihydroxyvitamin D3 (ED-71) on the modeling of bone in distraction osteogenesis. The tibiae of 30 rabbits were lengthened by 10 mm in 10 days. Following osteotomy, ED-71 (0.05 microg/kg) was administered subcutaneously twice a week to the ED-71 group un...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(98)00179-3

    authors: Yamane K,Okano T,Kishimoto H,Hagino H

    更新日期:1999-03-01 00:00:00

  • Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

    abstract::Twenty patients with mild Paget's disease of bone were given either 20 (10 patients) or 40 mg alendronate daily for 6 months. The 20-mg dose was well tolerated, but in 3 patients on 40 mg/d alendronate, the treatment was withdrawn after 3-5 months because of gastric and oesophageal disturbances. Urinary hydroxyproline...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/8756-3282(94)90818-4

    authors: Adami S,Mian M,Gatti P,Rossini M,Zamberlan N,Bertoldo F,Lo Cascio V

    更新日期:1994-07-01 00:00:00

  • Bone remodeling and bone matrix quality before and after menopause in healthy women.

    abstract::Acceleration of remodeling activity after menopause leads to bone loss and fragility, however, whether this is associated with modifications of bone matrix quality has been less studied. The impact of variation in bone remodeling rate on bone matrix has been studied mainly in pathologies or anti-osteoporotic treatment...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.08.003

    authors: Farlay D,Bala Y,Rizzo S,Bare S,Lappe JM,Recker R,Boivin G

    更新日期:2019-11-01 00:00:00

  • Granulocyte-macrophage colony-stimulating factor-dependent CD11c-positive cells differentiate into active osteoclasts.

    abstract::Levels of circulating cytokines are elevated in inflammatory diseases. Previously, it was shown that interleukin (IL-)17A, in synergism with 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and tumor necrosis factor α (TNFα), induces the release of granulocyte-macrophage colony-stimulating factor (GM-CSF) by murine osteoblasts ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.01.036

    authors: Ruef N,Dolder S,Aeberli D,Seitz M,Balani D,Hofstetter W

    更新日期:2017-04-01 00:00:00

  • Paradoxical Sost gene expression response to mechanical unloading in metaphyseal bone.

    abstract::The Sost gene encodes Sclerostin, an inhibitor of Wnt-signaling, generally considered a main response gene to mechanical loading in bone. Several papers describe that unloading leads to upregulation of Sost, which in turn may lead to loss of bone. These studies were based on whole bone homogenates or cortical bone. By...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.01.018

    authors: Macias BR,Aspenberg P,Agholme F

    更新日期:2013-04-01 00:00:00

  • Discordant recovery of bone mass and mechanical properties during prolonged recovery from disuse.

    abstract::Profound bone loss at weight bearing sites is a primary effect of long-duration spaceflight. Moreover, a significant increase in estimated fracture risk remains even 1 year after returning to Earth; hence, it is important to define how quickly bone integrity can recover following prolonged disuse. This study character...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.09.021

    authors: Shirazi-Fard Y,Kupke JS,Bloomfield SA,Hogan HA

    更新日期:2013-01-01 00:00:00

  • Angiotensin II triggers knee joint lesions in experimental osteoarthritis.

    abstract:OBJECTIVES:This study aimed to evaluate the involvement of Angiotensin II (Ang II) in joint lesions associated with osteoarthritis (OA) in vitro and in vivo. METHODS:Chondrocyte cultures were obtained from knee joints of neonatal rats and stimulated with Ang II/MIA/ACE inhibitors. In vivo, rats treated or not with the...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2021.115842

    authors: de Sá GA,Dos Santos ACPM,Nogueira JM,Dos Santos DM,Amaral FA,Jorge EC,Caliari MV,Queiroz-Junior CM,Ferreira AJ

    更新日期:2021-01-07 00:00:00

  • Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density.

    abstract::Juvenile osteoporosis (JO) is characterized by bone fragility during development, low bone mass and absence of extraskeletal features. Heterozygous loss-of-function mutations in LRP5 have been found in a few patients, but bone tissue and bone material abnormalities associated with such mutations have not been determin...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2013.07.020

    authors: Fahiminiya S,Majewski J,Roughley P,Roschger P,Klaushofer K,Rauch F

    更新日期:2013-11-01 00:00:00

  • Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment.

    abstract::A stabilized tibia fracture model was used in young (8-week old) and aged (1-year old) mice to define the relative bone regenerative potential and the relative responsiveness of the periosteal progenitor population with aging and PTH 1-34 (PTH) systemic therapy. Bone regeneration was assessed through gene expressions,...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.02.002

    authors: Yukata K,Xie C,Li TF,Takahata M,Hoak D,Kondabolu S,Zhang X,Awad HA,Schwarz EM,Beck CA,Jonason JH,O'Keefe RJ

    更新日期:2014-05-01 00:00:00

  • Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice.

    abstract::Loss of bone and muscle mass are two major clinical complications among the growing list of chronic diseases that primarily affect elderly individuals. Persistent low-grade inflammation, one of the major drivers of aging, is also associated with both bone and muscle dysfunction in aging. Particularly, chronic activati...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.04.012

    authors: Davis HM,Essex AL,Valdez S,Deosthale PJ,Aref MW,Allen MR,Bonetto A,Plotkin LI

    更新日期:2019-07-01 00:00:00

  • Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model.

    abstract:INTRODUCTION:While the anti-resorptive effects of the bisphosphonates (BPs) are well documented, many questions remain about their mechanisms of action, particularly following long-term use. This study evaluated the effects of alendronate (Ale) treatment on TGF-β1 signaling in mesenchymal stem cells (MSCs) and osteocyt...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.10.017

    authors: Jia J,Yao W,Amugongo S,Shahnazari M,Dai W,Lay YA,Olvera D,Zimmermann EA,Ritchie RO,Li CS,Alliston T,Lane NE

    更新日期:2013-01-01 00:00:00